manual therapy
Showing 9976 - 10000 of >10,000
Hypertriglyceridemia Trial in Canada, Netherlands, United States (evinacumab, Placebo)
Active, not recruiting
- Hypertriglyceridemia
- evinacumab
- Placebo
-
Newport Beach, California
- +38 more
Sep 30, 2022
Mind-body Connection While Learning About Common Osteopathic
Not yet recruiting
- Medical School Syndrome
- Mind Body Awareness
- Osteopathic Manual Manipulation (OMM) Curriculum
-
New York, New YorkTouro College of Osteopathic Medicine
Jul 27, 2022
Chronic Pain, Opioid Use, and Epidermal Nerve Fiber Density
Recruiting
- Chronic Pain
- +2 more
-
Kansas City, KansasUniversity of Kansas Health System
Jun 14, 2022
Immune Thrombocytopenia Trial (Daratumumab Injection)
Not yet recruiting
- Immune Thrombocytopenia
- Daratumumab Injection
- (no location specified)
Sep 28, 2022
Prostate Cancer, 18F- Fluorocholine, PSMA PET Trial (Radiopharmaceutical 18F-JK-PSMA-7, Radiopharmaceutical 18F-Fluorocholine)
Not yet recruiting
- Prostate Cancer
- +5 more
- Radiopharmaceutical 18F-JK-PSMA-7
- Radiopharmaceutical 18F-Fluorocholine
- (no location specified)
Nov 17, 2022
HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy Trial (SHR-A1811,
Not yet recruiting
- HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy
- SHR-A1811
- Trastuzumab Emtansine
- (no location specified)
Nov 7, 2023
Imaging Parameters and DME Treatment Response
Recruiting
- Diabetic Macular Edema
- Diabetic Retinopathy
- No intervention
-
Durham, North CarolinaDuke Eye Center
Jan 3, 2023
Insomnia, Harmful; Use, Alcohol Trial in Rochester (Insomnia Treatment, Education Control)
Not yet recruiting
- Insomnia
- Harmful; Use, Alcohol
- Insomnia Treatment
- Education Control
-
Rochester, New YorkUniversity of Rochester Medical Center
Jul 25, 2023
Esophageal Squamous Cell Carcinoma (ESCC) Trial in Japan, Taiwan (Pembrolizumab, Coformulation favezelimab/pembrolizumab,
Recruiting
- Esophageal Squamous Cell Carcinoma (ESCC)
- Pembrolizumab
- +5 more
-
Milan, Lombardia, Italy
- +13 more
Jan 3, 2023
Wound, Venous Leg Ulcer, Diabetic Foot Ulcer Trial in London, Norwich (geko device)
Recruiting
- Wound
- +3 more
- geko device
-
London, United Kingdom
- +1 more
Aug 4, 2022
2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2-
Recruiting
- Advanced Breast Cancer
- +2 more
-
Ancona, Italy
- +28 more
Jul 27, 2022
Breast Cancer Trial in Nanjing (Neoadjuvant therapy: TCbHPy, Neoadjuvant therapy: TCbHP)
Not yet recruiting
- Breast Cancer
- Neoadjuvant therapy: TCbHPy
- Neoadjuvant therapy: TCbHP
-
Nanjing, Chinathe First Affiliated Hospital of Nanjing Medical University
Jul 4, 2022
Reablement Service by Professionals in Taiwan: Review and
Not yet recruiting
- Long-term Care
- interview
- (no location specified)
Oct 11, 2021
Stroke, Hemiplegia, Subcortical Infarction Trial in Seongnam-si, Daejeon (Low-frequency rTMS (experimental), Low-frequency rTMS
Not yet recruiting
- Stroke
- +2 more
- Low-frequency rTMS (experimental)
- Low-frequency rTMS (sham comparator)
-
Seongnam-si, Korea, Gyeonggi-do, Korea, Republic of
- +1 more
Sep 7, 2022
Hepatocellular Carcinoma Non-resectable Trial in Honolulu (Fluorine-18 fluorocholine)
Recruiting
- Hepatocellular Carcinoma Non-resectable
- Fluorine-18 fluorocholine
-
Honolulu, HawaiiThe Queen's Medical Center
Mar 28, 2022
Melanoma Trial in Shinjuku (Pembrolizumab and Imatinib mesylate)
Recruiting
- Melanoma
- Pembrolizumab and Imatinib mesylate
-
Shinjuku, Tokyo, JapanKeio University Hospital
Mar 29, 2022
Nasopharyngeal Carcinoma, Neoadjuvant Therapy, PD-1 Inhibitor Trial (PD-1 inhibitor+GP, GP)
Not yet recruiting
- Nasopharyngeal Carcinoma
- +2 more
- PD-1 inhibitor+GP
- GP
- (no location specified)
Jul 1, 2022
Generalized Convulsive Status Epilepticus Trial in Sohag (Ketamine, Midazolam, Placebo)
Recruiting
- Generalized Convulsive Status Epilepticus
- Ketamine
- +2 more
-
Sohag, EgyptSohag University Hospital
Mar 21, 2023
HIV Infected Individuals in Assiut Governorate, Egypt
Not yet recruiting
- HIV Infections
- (no location specified)
Jul 12, 2023
Breast Cancer Trial in Amsterdam (anthracycline-based, docetaxel and capecitabine, tamoxifen)
Completed
- Breast Cancer
- anthracycline-based
- +3 more
-
Amsterdam, NetherlandsNetherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Nov 16, 2022
Periodontitis, Halitosis, Tongue Condition Trial (tongue scraper)
Not yet recruiting
- Periodontitis
- +2 more
- tongue scraper
- (no location specified)
Oct 13, 2023
Acute Coronary Syndrome Trial in Kyoto (No aspirin, 1-month DAPT)
Recruiting
- Acute Coronary Syndrome
- No aspirin
- 1-month DAPT
-
Kyoto, JapanKyoto University Graduate School of Medicine
Nov 16, 2022
Adhesive Capsulitis of Shoulder Trial in Jeddah (ESWT+ traditional physical therapy treatment, Placebo shockwave + traditional
Recruiting
- Adhesive Capsulitis of Shoulder
- ESWT+ traditional physical therapy treatment
- Placebo shockwave + traditional physical therapy treatment
-
Jeddah, Mecca, Saudi ArabiaAl-Thager General Hospital
Mar 5, 2023
Minimal Change Disease, Focal Segmental Glomerulosclerosis Trial in United States (VB119)
Recruiting
- Minimal Change Disease
- Focal Segmental Glomerulosclerosis
-
Los Angeles, California
- +7 more
Jul 19, 2022
Surveying Patient's Interest in Robotic Rehabilitation Device
Recruiting
- Stroke, Acute
-
Buffalo, New YorkBuffalo General Hospital
Jun 8, 2022